Sanofi appoints PwC as statutory auditor for five-year term

1 min read     Updated on 30 Jun 2026, 04:55 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Sanofi Consumer Healthcare India Ltd appointed M/s. Price Waterhouse & Co Chartered Accountants LLP as statutory auditor for a five-year term ending in 2031, filling a casual vacancy caused by the resignation of M/s. Kalyaniwalla & Mistry LLP.

powered bylight_fuzz_icon
44029072

*this image is generated using AI for illustrative purposes only.

Sanofi Consumer Healthcare India Ltd appointed M/s. Price Waterhouse & Co Chartered Accountants LLP as its statutory auditor during its 3rd Annual General Meeting held on June 26, 2026. The appointment fills a casual vacancy caused by the resignation of M/s. Kalyaniwalla & Mistry LLP and re-appoints the firm for a five-year term. The firm will hold office until the conclusion of the 8th AGM to be held in the year 2031. This decision was finalized pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Details

The appointment is effective from May 25, 2026, for the casual vacancy until the conclusion of the 3rd AGM. Thereafter, the term extends for five consecutive years commencing from the conclusion of the 3rd AGM until the conclusion of the 8th AGM in 2031. M/s. Price Waterhouse & Co Chartered Accountants LLP is registered with the Institute of Chartered Accountants of India (Firm Registration No. 304026E/E300009).

Auditor Profile

Particulars Details
Firm Name M/s. Price Waterhouse & Co Chartered Accountants LLP
Registration No. 304026E/E300009
Established 1991
LLP Conversion 2014
Registered Office Plot No. 56 & 57, Block DN, Sector V, Salt Lake, Kolkata - 700 091
Branch Offices 17
Assurance Partners More than 120 (as of April 1, 2026)
Network Member firm of Price Waterhouse & Affiliates (Network Registration No. NRN/E/14)

The firm is primarily engaged in providing assurance and auditing services and holds a valid peer review certificate. It audits various companies listed on stock exchanges in India.

Historical Stock Returns for Sanofi Consumer Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.34%-1.08%-3.11%+4.22%-12.48%-6.87%

What factors led to the resignation of the previous auditor, M/s. Kalyaniwalla & Mistry LLP?

How will the transition to a new auditor impact Sanofi Consumer Healthcare India's financial reporting timeline for the upcoming fiscal year?

What strategic benefits does Sanofi expect to gain from appointing a Big Four affiliate firm for a five-year term?

Sanofi Consumer Healthcare
View Company Insights
View All News
like20
dislike

Sanofi Consumer Healthcare fixes ₹75 dividend record date

2 min read     Updated on 06 Jun 2026, 11:15 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Sanofi Consumer Healthcare India Limited announced a final dividend of ₹75 per share for FY25, with a record date of June 19, 2026, and payment on July 9, 2026. The 3rd AGM on June 26, 2026, will cover financial statement adoption, auditor appointments, and director re-appointment.

powered bylight_fuzz_icon
42141091

*this image is generated using AI for illustrative purposes only.

Sanofi Consumer Healthcare India Limited has fixed Friday, June 19, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹75 per equity share for the financial year ended December 31, 2025. The dividend will be paid on July 9, 2026, to members whose names appear on the Register of Members or as Beneficial Owners on the record date. The announcement was made in the notice for the 3rd Annual General Meeting (AGM) scheduled to be held on June 26, 2026, through Video Conferencing and Other Audio Visual Means.

The AGM will transact ordinary business, including the adoption of the audited standalone financial statements for the year ended December 31, 2025. Shareholders will consider the re-appointment of Mr. Stanislas Camart, a Non-Executive Director who retires by rotation and is eligible for re-appointment. Mr. Camart has served as the CHC Chief Accounting Officer and Head of Global Business Services at Opella since October 2022.

A key agenda item involves the appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors. The firm was appointed by the Board on May 25, 2026, to fill a casual vacancy caused by the resignation of M/s. Kalyaniwalla & Mistry LLP. Shareholders are asked to approve this appointment effective from May 25, 2026, until the conclusion of the 3rd AGM, and subsequently for a term of five years ending with the 8th AGM in 2031.

The proposed fees for the new auditors include ₹1.20 million for three limited reviews and ₹2.95 million for the statutory audit, excluding out-of-pocket expenses. The Board noted that the fees payable to the new auditors are lower than the fee increase sought by the outgoing auditors. The firm is registered with the Institute of Chartered Accountants of India and is a member firm of Price Waterhouse & Affiliates.

Shareholders will also ratify the remuneration of M/s. Kishore Bhatia & Associates, Cost Accountants, for the audit of cost records for the financial year ending December 31, 2026. The ratified remuneration is ₹3,15,000 plus applicable taxes and reimbursement of out-of-pocket expenses. The Register of Members will remain closed from June 20, 2026, to June 26, 2026.

Key AGM Dates

Event Date
AGM Date Friday, June 26, 2026
Remote e-voting Start Tuesday, June 23, 2026 (9:00 A.M. IST)
Remote e-voting End Thursday, June 25, 2026 (5:00 P.M. IST)
Book Closure Saturday, June 20, 2026 to Friday, June 26, 2026
Dividend Record Date Friday, June 19, 2026
Dividend Payment Date Friday, July 9, 2026

Historical Stock Returns for Sanofi Consumer Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.34%-1.08%-3.11%+4.22%-12.48%-6.87%

How will the change in statutory auditors impact the company's financial reporting and internal controls moving forward?

What factors influenced the Board's decision to propose a final dividend of ₹75 per share for FY2025?

Will the re-appointment of Mr. Stanislas Camart bring any strategic shifts to Sanofi Consumer Healthcare India's operations?

Sanofi Consumer Healthcare
View Company Insights
View All News
like20
dislike

More News on Sanofi Consumer Healthcare

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-12.48%